Drugs / Gum Arabic
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT04978103 | Dec 2019 → Jan 2021 | metabolic syndrome X | University of Khartoum | Completed | No outcome recorded |
| Phase 2 | NCT03348241 | Oct 2015 → Aug 2016 | chemotherapy-induced oral mucositis | University of Science and Technology, Yemen | Completed | No outcome recorded |
| Phase 2/32 trials | ||||||
| Phase 2/3 | NCT04422860 | Oct 2020 → Sep 2021 | dental caries | Cairo University | Unknown | No outcome recorded |
| Phase 2/3 | NCT03684993 | Dec 2019 → Jan 2020 | smooth surface dental caries | Cairo University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gum Arabic | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03348241 ↗ |
| Known as | Arabic, Gum | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03684993 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “natural gum of acacia tree: Antimicrobial, anti-inflammatory medicinal plant used as a traditional oral hygiene substance (anticariogenic).” NCT03684993 ↗ |
| Route | Oral | “30 grams Gum Arabic per day as oral solution” NCT03348241 ↗ |